Diagnos Inc.
DGNOF
$0.23
$0.026.95%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.50% | -53.64% | -55.33% | -45.57% | -33.73% |
| Total Depreciation and Amortization | 4.66% | 4.31% | -6.81% | -10.98% | 10.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.65% | -6.81% | -27.79% | 32.33% | 8.53% |
| Change in Net Operating Assets | -90.56% | 103.68% | -215.12% | -140.94% | 27.76% |
| Cash from Operations | -51.93% | -16.82% | -124.57% | -62.62% | -50.63% |
| Capital Expenditure | 48.08% | -- | -21.43% | -130.77% | -18.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 186.89% | 419.90% | -266.78% | -825.71% | -- |
| Cash from Investing | 186.24% | 419.13% | -269.57% | -841.91% | -25,013.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -268.52% | -1,424.81% | -553.63% | -11.67% | -32.17% |
| Issuance of Common Stock | -- | -- | 250.63% | 141.49% | 1,219.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.71% | 4.89% | 17.35% | 5.54% | -27.66% |
| Cash from Financing | -104.62% | -156.84% | 245.60% | 165.66% | 2,179.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.20% | 135.86% | -84.95% | -1,098.41% | 236.60% |